Exane Derivatives’s Anaplan, Inc. PLAN Stock Holding History

Exane Derivatives’s Portfolio PLAN Stock Details PLAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,526	Closed	-$294K	–	1061
2022 Q1	$294K	Sell	4,526 -518	-10%	-$25.2K	0.08%	251
2021 Q4	$231K	Buy	5,044 +3,656	+263%	+$202K	0.06%	311
2021 Q3	$84.5K	Buy	1,388 +205	+17%	+$12.2K	0.02%	548
2021 Q2	$64.4K	Buy	+1,183	New	+$65.8K	0.01%	610
2021 Q1	–	Sell	-7	Closed	-$472	–	976
2020 Q4	$503	Buy	+7	New	+$455	﹤0.01%	739

Other funds holding PLAN

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Exane Derivatives's PLAN Position: Q2 2022 in Review

Exane Derivatives sold out of Anaplan, Inc. (PLAN) in Q2 2022, closing a stake of 4,526 shares — an estimated $294K sold.

Exane Derivatives first reported a position in PLAN in Q4 2020 and held it in 5 quarters. The position peaked at $294K in Q1 2022. 2 funds tracked by Wall St. Rank hold PLAN as of Q2 2022.

Exane Derivatives reported no remaining Anaplan, Inc. position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 4,526 Anaplan, Inc. shares in Q2 2022, an estimated $294K.
Exane Derivatives first reported a position in Anaplan, Inc. in Q4 2020 and held it in 5 quarters.
Exane Derivatives's Anaplan, Inc. position peaked at $294K in Q1 2022.
2 funds tracked by Wall St. Rank held Anaplan, Inc. as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.